{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:39:43Z","timestamp":1791070783790,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["MAT2013-47501-C2-2-R"],"award-info":[{"award-number":["MAT2013-47501-C2-2-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010801","name":"Xunta de Galicia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["2014\/043"],"award-info":[{"award-number":["2014\/043"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003176","name":"Ministerio de Educaci\u00f3n, Cultura y Deporte","doi-asserted-by":"publisher","award":["FPU13\/00342"],"award-info":[{"award-number":["FPU13\/00342"]}],"id":[{"id":"10.13039\/501100003176","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.ejpb.2018.01.009","type":"journal-article","created":{"date-parts":[[2018,1,19]],"date-time":"2018-01-19T17:24:41Z","timestamp":1516382681000},"page":"85-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Development and characterisation of chondroitin sulfate- and hyaluronic acid-incorporated sorbitan ester nanoparticles as gene delivery systems"],"prefix":"10.1016","volume":"125","author":[{"given":"I.","family":"Fernandez-Pi\u00f1eiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pensado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Badiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2018.01.009_b0005","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature15818","article-title":"Gene therapy returns to centre stage","volume":"526","author":"Naldini","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2018.01.009_b0010","doi-asserted-by":"crossref","first-page":"20143003","DOI":"10.1098\/rspb.2014.3003","article-title":"Gene therapy: progress and predictions","volume":"282","author":"Collins","year":"2015","journal-title":"Procee. Royal Soc. B: Biol. Sci."},{"key":"10.1016\/j.ejpb.2018.01.009_b0015","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1517\/14712598.2016.1134480","article-title":"Vectors and strategies for nonviral cancer gene therapy","volume":"16","author":"Pahle","year":"2016","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.ejpb.2018.01.009_b0020","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/cgt.2017.16","article-title":"New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles","volume":"24","author":"Zaimy","year":"2017","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ejpb.2018.01.009_b0025","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s13346-013-0159-6","article-title":"Diseases originate and terminate by genes: unraveling nonviral gene delivery","volume":"3","author":"Swami","year":"2013","journal-title":"Drug Deliv. Trans. Res."},{"key":"10.1016\/j.ejpb.2018.01.009_b0030","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ejpb.2018.01.009_b0035","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/24\/37\/375101","article-title":"A novel local anti-colorectal cancer drug delivery system: negative lipidoid nanoparticles with a passive target via a size-dependent pattern","volume":"24","author":"Ding","year":"2013","journal-title":"Nanotechnology"},{"key":"10.1016\/j.ejpb.2018.01.009_b0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4155\/tde.12.128","article-title":"Recent developments and perspectives on gene therapy using synthetic vectors","volume":"4","author":"Schlenk","year":"2013","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ejpb.2018.01.009_b0045","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.biomaterials.2016.09.019","article-title":"Multifunctional \u201ccore-shell\u201d nanoparticles-based gene delivery for treatment of aggressive melanoma","volume":"111","author":"Li","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2018.01.009_b0050","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.biomaterials.2009.10.012","article-title":"Tissue-specific gene delivery via nanoparticle coating","volume":"31","author":"Harris","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2018.01.009_b0055","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/mabi.201300302","article-title":"HA-coated chitosan nanoparticles for CD44-mediated nucleic acid delivery","volume":"13","author":"Almalik","year":"2013","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ejpb.2018.01.009_b0060","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.addr.2013.05.002","article-title":"Polysaccharide-based nucleic acid nanoformulations","volume":"65","author":"Raemdonck","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2018.01.009_b0065","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijpharm.2015.02.022","article-title":"Hyaluronic acid conjugated beta-cyclodextrin-oligoethylenimine star polymer for CD44-targeted gene delivery","volume":"483","author":"Yin","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.01.009_b0070","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.2217\/nnm.14.45","article-title":"Efficient targeted gene delivery by a novel PAMAM\/DNA dendriplex coated with hyaluronic acid","volume":"9","author":"Urbiola","year":"2014","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.ejpb.2018.01.009_b0075","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ijpharm.2014.11.012","article-title":"Enhanced gene delivery efficiency of cationic liposomes coated with PEGylated hyaluronic acid for anti P-glycoprotein siRNA: a potential candidate for overcoming multi-drug resistance","volume":"477","author":"Ran","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.01.009_b0080","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1248\/bpb.b13-00768","article-title":"Ternary complex of plasmid DNA electrostatically assembled with polyamidoamine dendrimer and chondroitin sulfate for effective and secure gene delivery","volume":"37","author":"Imamura","year":"2014","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2018.01.009_b0085","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.biomaterials.2012.09.049","article-title":"Polyethyleneimine\/DNA polyplexes with reduction-sensitive hyaluronic acid derivatives shielding for targeted gene delivery","volume":"34","author":"He","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2018.01.009_b0090","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/mt.2010.262","article-title":"Antifibrotic effect of MMP13-encoding plasmid DNA delivered using polyethylenimine shielded with hyaluronic acid","volume":"19","author":"Kim","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejpb.2018.01.009_b0095","first-page":"1053","article-title":"Exogenous chondroitin sulfate glycosaminoglycan associate with arginine-rich peptide-DNA complexes to alter their intracellular processing and gene delivery efficiency","volume":"2015","author":"Naik","year":"1848","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejpb.2018.01.009_b0100","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/macp.201000167","article-title":"Preparation of highly stable biodegradable polymer micelles by coating with polyion complex","volume":"211","author":"Ohya","year":"2010","journal-title":"Macromol. Chem. Phys."},{"key":"10.1016\/j.ejpb.2018.01.009_b0105","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jconrel.2010.11.008","article-title":"Evaluation of polyanion-coated biodegradable polymeric micelles as drug delivery vehicles","volume":"155","author":"Ohya","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.01.009_b0110","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.carbpol.2015.07.063","article-title":"Chondroitin sulfate-based nanocarriers for drug\/gene delivery","volume":"133","author":"Zhao","year":"2015","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejpb.2018.01.009_b0115","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/polb.22259","article-title":"Biomedical applications of biodegradable polymers","volume":"49","author":"Ulery","year":"2011","journal-title":"J. Polym. Sci. B. Polym. Phys."},{"key":"10.1016\/j.ejpb.2018.01.009_b0120","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.2147\/IJN.S36111","article-title":"The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles","volume":"7","author":"Frohlich","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2018.01.009_b0125","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejpb.2008.09.015","article-title":"Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy","volume":"71","author":"del Pozo-Rodriguez","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.01.009_b0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijpharm.2014.09.032","article-title":"Anionic nanoparticles based on Span 80 as low-cost, simple and efficient non-viral gene-transfection systems","volume":"476","author":"Pensado","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.01.009_b0135","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijpharm.2015.11.020","article-title":"Characterization and comparison of two novel nanosystems associated with siRNA for cellular therapy","volume":"497","author":"Andre","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.01.009_b0140","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejpb.2016.05.002","article-title":"Structural analysis of nanosystems: solid Sorbitan esters nanoparticles (SSN) as a case study","volume":"104","author":"Pensado","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.01.009_b0145","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.nano.2016.06.007","article-title":"Span poly-L-arginine nanoparticles are efficient non-viral vectors for PRPF31 gene delivery: an approach of gene therapy to treat retinitis pigmentosa","volume":"12","author":"Pensado","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2018.01.009_b0150","unstructured":"A. Sanchez, B. Seijo, G.K. Zorzi, E.L. Carvalho, A. Pensado, Nanoparticulate systems prepared from sorbitan esters, (2013), WO2013068625 A1."},{"key":"10.1016\/j.ejpb.2018.01.009_b0155","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1517\/14712598.2016.1169269","article-title":"Recent advances on biocompatible and biodegradable nanoparticles as gene carriers","volume":"16","author":"Mokhtarzadeh","year":"2016","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.ejpb.2018.01.009_b0160","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jcis.2011.04.080","article-title":"Preparation and characterization of highly stable lipid nanoparticles with amorphous core of tuneable viscosity","volume":"360","author":"Delmas","year":"2011","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejpb.2018.01.009_b0165","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jconrel.2009.10.024","article-title":"An overview of liposome lyophilization and its future potential","volume":"142","author":"Chen","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.01.009_b0170","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijpharm.2016.06.125","article-title":"Hyaluronic acid-conjugated lipoplexes for targeted delivery of siRNA in a murine metastatic lung cancer model","volume":"514","author":"Leite Nascimento","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.01.009_b0175","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jconrel.2011.06.031","article-title":"Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response","volume":"156","author":"Mizrahy","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.01.009_b0180","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jconrel.2013.11.016","article-title":"Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery","volume":"174","author":"Park","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.01.009_b0185","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ejpb.2013.06.003","article-title":"Hyaluronic acid-coated liposomes for active targeting of gemcitabine","volume":"85","author":"Arpicco","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117312547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117312547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T12:28:41Z","timestamp":1656937721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641117312547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":37,"alternative-id":["S0939641117312547"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.01.009","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and characterisation of chondroitin sulfate- and hyaluronic acid-incorporated sorbitan ester nanoparticles as gene delivery systems","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}